BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 18, 2003
View Archived Issues
Medtronic initiates Talent(TM) Thoracic Stent Graft Study in the US
Read More
Caspase-3 inhibition preserves myocardial geometry and long-term function postinfarction in mice
Read More
Neramexane shows promise for the treatment of alcohol dependence
Read More
Antalarmin reduces volitional ethanol consumption in rats
Read More
Hyperforin, an antidepressant with a novel mechanism of action
Read More
Pharmacological profiles of novel dual D2/5-HT1A-acting antipsychotics
Read More
Antidepressant/anxiolytic effects of CP-154526 shown in a rat model of depression
Read More
Proton pump inhibitors and cytochrome P-450 polymorphism in GERD
Read More
Therapeutic benefits of rabeprazole in ulcers and GERD
Read More
BIA-2-024 and BIA-2-093 reported less neurotoxic than current antiepileptics
Read More
Fast and potent analgesic effects of AZD-3582 in a rat model of monoarthritis
Read More
First evidence of antiinflammatory effects induced by cilomilast in COPD patients
Read More
New thyroid receptor antagonists and their use described in Karo Bio patent
Read More
Solvay scientists describe novel NK1 antagonists for pain, emesis, arthritis, etc.
Read More
Novartis claims MMP inhibitors with utility in neuropathic pain therapy
Read More
Gruenenthal patent covers new NBTI analogues with potential as analgesic agents
Read More
New NR2B NMDA antagonists in early development at Merck
Read More
Novel factor Xa inhibitors prepared and tested at Merck KGaA
Read More
New M3 antagonists/PDE4 inhibitors for COPD and other uses claimed by UCB team
Read More
Pliva presents azulene-based inhibitors of TNF-alpha and/or IL-1 production
Read More
Two phase III studies for Retaane planned for January
Read More
BTG seeks development partners for PDE-4 inhibitor portfolio
Read More
Encouraging results for Crucell's experimental malaria vaccine
Read More
Dendreon grants Kirin HLA-DR antibody license, regains Asian Provenge rights
Read More
Swiss prenotification of intent to approve Erbitux
Read More
Nobex to reacquire modified insulin molecule rights from GlaxoSmithKline
Read More
Arthron compounds produce sustained suppression of rheumatoid arthitis
Read More
Sinovac new name for Net Force Systems
Read More
Subcutaneous CERA increases plasma hemoglobin in patients with chronic renal anemia
Read More
Good safety profile found for pyridoxamine in patients with diabetic nephropathy
Read More